Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ingredion (INGR) Shares Outstanding (Weighted Average) (2016 - 2025)

Ingredion (INGR) has disclosed Shares Outstanding (Weighted Average) for 14 consecutive years, with $64.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) fell 1.83% year-over-year to $64.4 million, compared with a TTM value of $64.4 million through Sep 2025, down 1.83%, and an annual FY2024 reading of $65.5 million, down 0.76% over the prior year.
  • Shares Outstanding (Weighted Average) was $64.4 million for Q3 2025 at Ingredion, roughly flat from $64.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $67.1 million in Q4 2021 and bottomed at $64.4 million in Q3 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $65.7 million, with a median of $65.8 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Weighted Average) rose 0.46% in 2023, then fell 1.83% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $67.1 million in 2021, then decreased by 1.34% to $66.2 million in 2022, then dropped by 0.3% to $66.0 million in 2023, then decreased by 0.76% to $65.5 million in 2024, then decreased by 1.68% to $64.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for INGR at $64.4 million in Q3 2025, $64.5 million in Q2 2025, and $64.5 million in Q1 2025.